The global antibody production market is anticipated to grow at a CAGR
of 12.4 % during the forecasted period

The key trend which is positively influencing the growth of antibody
production market is increasing funding from government and private
organizations for research activities. Increasing R&D expenditure in
pharmaceuticals by biotechnology companies and improved approval rate of
therapeutic antibodies by regulatory authorities majorly contributes to
the growth of the global connected mining market during the forecast
period.

However, cost constraint related to the adoption of membrane filter is
the factor that restrains the growth of the global connected mining
market during the forecast period. Further, the key opportunities for
the global antibody production market are increasing risk of infectious
diseases and rising demand for protein therapeutics, these are the
factors which will help to grow the global antibody production market.

The global angiography devices market is led by North America as it
attained major market share in 2016. In North America region, U.S and
Canada are the largest market shareholders. In the U.S., rising
incidences of cancer, increased government funding for medical research
and technological advancements will drive the antibody production
market. Moreover, in Canada, regulatory approvals, authorizations for
use of monoclonal antibodies, and the need for quality cancer treatment
are likely to boost the antibody production market. Further,
Asia-Pacific is expected to be the fastest growing region.